Author

Adriana Moţoc

Observed names: A Motoc, A. Motoc, A. Moţoc, Adriana Motoc, Motoc A, Motoc, A.

OpenAlex ID: A5000219824

Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy

2018 · Cihan Yurdaydin, Zaigham Abbas, et al. · Journal of Hepatology · 116

Clinical and virological heterogeneity of hepatitis delta in different regions world‐wide: The Hepatitis Delta International Network ( HDIN )

2017 · Anika Wranke, Lourdes M. Pinheiro Borzacov, et al. · Liver International · 96

PDF

Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials

2015 · Gregory J. Dore, Brian Conway, et al. · Journal of Hepatology · 68

PDF

Hepatitis Delta Virus Infection in Romania: Prevalence and Risk Factors

2015 · Liana Gheorghe, Irma Eva Csiki, et al. · Journal of Gastrointestinal and Liver Diseases · 56

PDF

Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight.

2008 · L Santacroce, R Cagiano, et al. · PubMed · 39

P0847 : Malachite-II: Phase 3b trial of ombitasvir/paritaprevir/r and dasabuvir + ribavirin or telaprevir + peginterferon/ribavirin in peginterferon/ribavirin treatment-experienced adults with HCV genotype 1

2015 · G. Dore, B. Knysz, et al. · Journal of Hepatology · 7

Our experience in Helicobacter pylori infection and gastric MALToma.

2008 · T Losacco, R Cagiano, et al. · PubMed · 7

Genetic variation in FCER1A predicts peginterferon alfa‐2a‐induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B

2019 · Lai Wei, Vedran Pavlovic, et al. · Journal of Viral Hepatitis · 5

PDF

Diversity of clinical presentation and virological characteristics of hepatitis delta in different regions world-wide: results of the Hepatitis Delta International network

2017 · A. Wranke, S. Hardtke, et al. · Journal of Hepatology · 4

A Real Life Boceprevir Use in Treatment-Experienced HCV Genotype 1 Patients with Advanced Fibrosis

2014 · Liana Gheorghe, Speranta Iacob, et al. · Journal of Gastrointestinal and Liver Diseases · 3

P0842 : Malachite-I: Phase 3B Trial of ombitasvir/paritaprevir/r and dasabuvir +/− ribavirin or telaprevir + peginterferon/ribavirin in treatment-naïve adults with HCV genotype 1

2015 · B. Conway, E. Janczewska, et al. · Journal of Hepatology · 2

P0638 : Global epidemiology of hepatitis delta: First data from the hepatitis delta international network

2015 · S. Hardtke, Z. Abbas, et al. · Journal of Hepatology · 2

1012 MALACHITE-I: Phase 3b Trial of Ombitasvir/Paritaprevir/R and Dasabuvir +/- Ribavirin or Telaprevir + Peginterferon/Ribavirin in Treatment-Naïve Adults With HCV Genotype 1

2015 · Brian Conway, Ewa Janczewska, et al. · Gastroenterology · 2

412 Prevalence, Virological and Clinical Characteristics of Chronic Hepatitis Delta Virus Infection (chd) in Romania

2013 · L. Gheorghe, I.E. Csiki, et al. · Journal of Hepatology · 2

Comparative methods for genotyping hepatitis C virus isolates from Romania.

2009 · Gabriela Oprişan, Camelia Szmal, et al. · PubMed · 2

Tratamentul Cirozei Hepatice Cu Virus Hepatitic C, Cu Interferon Pegylat-ribavirină Şi Interferon Free – Studiu Comparativ

2016 · Grupul de lucru proiect PN II PT PCCA 88/2011, S.A. Florescu, et al. · Romanian Journal of Infectious Diseases

PDF

Treatments of Hepatitis C Virus Liver Cirrhosis With Pegylat Interferon-ribavirin and Interferon Free – Comparative Study

2016 · Team of PN II PT PCCA 88/2011 project, S.A. Florescu, et al. · Romanian Journal of Infectious Diseases

PDF

Diversity of clinical presentation and virological characteristics of hepatitis delta: The hepatitis Delta International network (HDIN)

2016 · A Wranke, S Hardtke, et al. · Zeitschrift für Gastroenterologie

Genetic Variation in FCER1A Gene Predicts Sustained HBsAg Clearance in East-Asian Patients Treated with Pegylated Interferon Alfa-2a (40kd): The “Peg-Be-Yond” Study

2016 · L. Wei, V. Pavlovic, et al. · Journal of Hepatology

Tu1015 MALACHITE-II: Phase 3b Trial of Ombitasvir/Paritaprevir/R and Dasabuvir + Ribavirin or Telaprevir + Peginterferon/Ribavirin in Peginterferon/Ribavirin Treatment-Experienced Adults With HCV Genotype 1

2015 · Gregory J. Dore, Brygida Knysz, et al. · Gastroenterology

Genomic Analysis of Hepatitis B Virus Strains Infecting Romanian Patients.

2015 · Sorin Dinu, Graţiela Târdei, et al. · PubMed

Randomized trials of ombitasvir/paritaprevir/r+dasabuvir±ribavirin vs telapre- vir+pegIFN/ribavirin in adults with genotype 1 HCV

2015 · Gregory J. Dore, Brian Conway, et al.

Su1294 Epidemiological Characteristics of Chronic Hepatitis DELTA Virus Infection (CHD) in Romania

2013 · Liana S. Gheorghe, Irma Csiki, et al. · Gastroenterology

PDF

Su1292 A Week-8 Model Predicting Early Virological Response (EVR) and Futility of Boceprevir (BOC) Based Triple Therapy Regimen in Treatment-Experienced Patients With Cirrhosis and Bridging Fibrosis: Results Fron the Real-Life Compasional (Romanian) Named Patients Program (NPP)

2013 · Liana S. Gheorghe, Speranta Iacob, et al. · Gastroenterology

Oprisan Gabriela - RAMI Nr.3 2009

2012 · Camelia Sultana, Cristiana Cristea, et al.

Works count: 28

Citation count: 411

H-index: 7

I10-index: 5